Safety and Anti-Tumor Activity of TYRA-200 in Advanced Cholangiocarcinoma With Activating FGFR2 Gene Alterations
Clinical trial NCT06160752 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06160752
- Sponsor
- Tyra Biosciences, Inc
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-22
- Primary completion
- 2026-09-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.